Zobrazeno 1 - 10
of 581
pro vyhledávání: ''
Autor:
Atsushi Naganuma, Hiroaki Naruse, Yuki Tamura, Takeshi Hatanaka, Satoru Kakizaki, Keitaro Hirai, Hidetoshi Yasuoka, Takashi Hoshino, Yuhei Suzuki, Ichiro Sakamoto, Hiroshi Tanaka, Tetsushi Ogawa
Publikováno v:
Clinical Journal of Gastroenterology. 15:177-184
We herein report a successfully treated case of huge ruptured hepatocellular carcinoma (HCC) by conversion hepatectomy after transarterial embolization (TAE) and lenvatinib therapy. A 33-year-old male patient with right hypochondralgia and liver tumo
Autor:
Andreas Steinbrecher, Bernhard Hellmich, Jens Minnerup, Thorsten Alexander Bley, Jana Becker, Markus Kraemer
Publikováno v:
Der Nervenarzt. 93:819-827
ZusammenfassungDie Riesenzellarteriitis (RZA) ist in der Altersgruppe der über 50-Jährigen die häufigste idiopathische systemische Vaskulitis. Die Erkrankung bedarf einer zeitnahen Diagnostik und Therapie, um schwere Komplikationen wie eine Erblin
Autor:
Joung-Liang Lan, Hsin-Hua Chen, Der-Yuan Chen, Yi-Ming Chen, Shih-Hsin Chang, Po-Hao Huang, Chia-Wei Hsieh, Kuo-Tung Tang
Publikováno v:
Clinical Rheumatology. 41:557-566
Adult-onset Still’s disease (AOSD) is a systemic inflammatory disorder with clinical heterogeneity. Although tocilizumab (TCZ), an interleukin (IL)-6 receptor inhibitor, is an effective treatment for AOSD, the evidence regarding its efficacy on sys
Autor:
Mohammad Maysara Asfari, Rondell P. Graham, Daniela S. Allende, Koji Hashimoto, Gianina Flocco, Federico Aucejo, Lisa Yerian, Fadi Niyazi, Carlos Romero-Marrero, K. V. Narayanan Menon, Bijan Eghtesad, Rocio Lopez, Baraa Abduljawad, Vedha Sanghi
Publikováno v:
Virchows Archiv. 480:335-347
Sustained virological response (SVR) to the treatment of recurrent HCV in liver transplant recipients has excellent clinical outcomes; however, little is known about the effects on allograft histology. The study aimed to assess the histology of the a
Publikováno v:
Clinical Rheumatology
Introduction Systemic sclerosis (SSc) is a systemic multi-organ disease. Raynaud’s phenomenon (RP) and digital ulcers (DUs) in SSc patients can be resistant to usual treatments. We studied the clinical benefits, capillaroscopy changes, and cost-eff
Autor:
Max Seidensticker, Bernhard Gebauer, Alberto Benito, Osman Öcal, Peter Malfertheiner, Kerstin Schütte, Irene Bargellini, Christoph J. Zech, Moritz Wildgruber, Otto M. van Delden, Bora Peynircioglu, Vincent Vandecaveye, Maciej Pech, Roberto Iezzi, Christian Sengel, Antonio Gasbarrini, Jens Ricke, Christian Loewe, Ricarda Seidensticker
Publikováno v:
European radiology. Springer Verlag
European Radiology
European Radiology
Objectives To evaluate the correlation between liver enhancement on hepatobiliary phase and liver function parameters in a multicenter, multivendor study. Methods A total of 359 patients who underwent gadoxetic acid–enhanced MRI using a standardize
Autor:
Yukinori Kurokawa, Junya Fujita, Tomono Kawase, Yutaka Kimura, Hiroshi Imamura, Hisato Kawakami, Masahiro Goto, Kazuhiro Nishikawa, Norimasa Fukushima, Shugo Ueda, Naotoshi Sugimoto, Jin Matsuyama, Taroh Satoh, Daisuke Sakai, Takao Tamura, Toshio Shimokawa
Publikováno v:
International Journal of Clinical Oncology. 26:1871-1880
To compare irinotecan-alone, paclitaxel-alone, and each combination chemotherapy with S-1 in patients with advanced gastric cancer (AGC) that is refractory to S-1 or S-1 plus cisplatin (SP). Patients with AGC after first-line chemotherapy with S-1 or
Autor:
Chinatsu Mori, Masato Matsuyama, Manabu Takamatsu, Takafumi Mie, Noriko Nishimura, Takaaki Furukawa, Takashi Sasaki, Dai Maruyama, Naoki Sasahira, Akiyoshi Kasuga, Tsuyoshi Takeda, Yuto Yamada, Masato Ozaka, Takeshi Okamoto
Publikováno v:
Clinical Journal of Gastroenterology
Primary pancreatic lymphomas are extremely rare, accounting for 0.1-0.5% of malignant lymphomas and about 0.2% of primary pancreatic tumors. They occur most commonly in the pancreatic head of elderly males, with diffuse large B-cell lymphoma being th
Autor:
Huanlin Wang, Noboru Harada, Kojiro Hata, Shinji Itoh, Katsuya Toshida, Tomonari Shimagaki, Tomoharu Yoshizumi, Hiroyuki Watanabe, Yoshihiro Nagao, Takeshi Kurihara, Yoko Makihara, Masaki Mori, Takeo Toshima
Publikováno v:
Surgery Today. 52:441-448
Lenvatinib (LEN) is a molecular-target drug, used for unresectable hepatocellular carcinoma (HCC). It is associated with adverse events (AEs), including hypertension, proteinuria, fatigue, and anorexia, which may force dose reduction or discontinuati
Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis
Autor:
Qian Gu, Guoyu Wang, Lianlian Mei, Inam Ullah, Jianling Bai, Xiaoxuan Gong, Zekang Ye, Chunjian Li, Yi Lu, John W. Eikelboom, Mingwen Yang, Chuchu Tan, Samee Abdus, Lu Shi
Publikováno v:
European Journal of Clinical Pharmacology. 77:1815-1823
This study aimed to investigate the pharmacodynamic effects of indobufen and low-dose aspirin in patients with coronary atherosclerosis. In the first phase, 218 patients with coronary atherosclerosis were randomly assigned to receive aspirin 100 mg o